Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)

INTRODUCTION: Recently, inhibition of programmed cell death 1 or its ligand has shown therapeutic effects on non-small cell lung cancer (NSCLC). However, the effectiveness of preoperative nivolumab monotherapy for stage I NSCLC remains unknown. The present study aimed to investigate the pathological...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open
Asıl Yazarlar: Kagimoto, Atsushi, Tsutani, Yasuhiro, Mimae, Takahiro, Miyata, Yoshihiro, Ikeda, Norihiko, Ito, Hiroyuki, Maniwa, Yoshimasa, Suzuki, Kenji, Tsuboi, Masahiro, Yoshimura, Kenichi, Umemoto, Seiji, Okada, Morihito
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Surgery
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7978092/
https://ncbi.nlm.nih.gov/pubmed/33737428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-043234
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller